ReP USP - Resultado da busca

Trabalho de evento-resumo
Analysis of the relationships between ZEB1, PTEN loss, TMPRSS2-ERG fusion and immune response biomarkers in Prostate Cancer (2021)
Souza, Luiz Paulo Chaves de; Costa, André Luiz Caliari ; Dutra, William Lautert; Melo, Camila Morais ; Albuquerque, Clarissa Gondim Picanço de; Vidotto, Thiago; Saggioro, Fabiano Pinto; Reis, Rodolfo Borges dos; Squire, Jeremy Andrew
Fonte: Resumos. Nome do evento: Congresso Brasileiro de Genética = Brazilian Congress of Genetics. Unidades: SVOI, FMRP
Assuntos: TRANSCRIÇÃO, NEOPLASIAS, IMUNOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Luiz Paulo Chaves de et al. Analysis of the relationships between ZEB1, PTEN loss, TMPRSS2-ERG fusion and immune response biomarkers in Prostate Cancer. 2021, Anais.. [Ribeirão Preto]: Sociedade Brasileira de Genética - SBG, 2021. Disponível em: https://www.sbg.org.br/anais. Acesso em: 05 set. 2024.
APA
Souza, L. P. C. de, Costa, A. L. C., Dutra, W. L., Melo, C. M., Albuquerque, C. G. P. de, Vidotto, T., et al. (2021). Analysis of the relationships between ZEB1, PTEN loss, TMPRSS2-ERG fusion and immune response biomarkers in Prostate Cancer. In Resumos. [Ribeirão Preto]: Sociedade Brasileira de Genética - SBG. Recuperado de https://www.sbg.org.br/anais
NLM
Souza LPC de, Costa ALC, Dutra WL, Melo CM, Albuquerque CGP de, Vidotto T, Saggioro FP, Reis RB dos, Squire JA. Analysis of the relationships between ZEB1, PTEN loss, TMPRSS2-ERG fusion and immune response biomarkers in Prostate Cancer [Internet]. Resumos. 2021 ;[citado 2024 set. 05 ] Available from: https://www.sbg.org.br/anais
Vancouver
Souza LPC de, Costa ALC, Dutra WL, Melo CM, Albuquerque CGP de, Vidotto T, Saggioro FP, Reis RB dos, Squire JA. Analysis of the relationships between ZEB1, PTEN loss, TMPRSS2-ERG fusion and immune response biomarkers in Prostate Cancer [Internet]. Resumos. 2021 ;[citado 2024 set. 05 ] Available from: https://www.sbg.org.br/anais
Artigo de periodico
Epithelial–mesenchymal transition signaling and prostate cancer stem cells: emerging biomarkers and opportunities for precision therapeutics (2021)
Souza, Luiz Paulo Chaves de; Melo, Camila Morais ; Saggioro, Fabiano Pinto ; Reis, Rodolfo Borges dos ; Squire, Jeremy Andrew
Fonte: Genes. Unidades: SVOI, FMRP
Assuntos: NEOPLASIAS PROSTÁTICAS, IMUNOTERAPIA, ONCOGENES, GENES SUPRESSORES DE TUMOR, MUTAÇÃO GENÉTICA, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Luiz Paulo Chaves de et al. Epithelial–mesenchymal transition signaling and prostate cancer stem cells: emerging biomarkers and opportunities for precision therapeutics. Genes, v. 12, n. 12, p. 1-18, 2021Tradução . . Disponível em: https://doi.org/10.3390/genes12121900. Acesso em: 05 set. 2024.
APA
Souza, L. P. C. de, Melo, C. M., Saggioro, F. P., Reis, R. B. dos, & Squire, J. A. (2021). Epithelial–mesenchymal transition signaling and prostate cancer stem cells: emerging biomarkers and opportunities for precision therapeutics. Genes, 12( 12), 1-18. doi:10.3390/genes12121900
NLM
Souza LPC de, Melo CM, Saggioro FP, Reis RB dos, Squire JA. Epithelial–mesenchymal transition signaling and prostate cancer stem cells: emerging biomarkers and opportunities for precision therapeutics [Internet]. Genes. 2021 ; 12( 12): 1-18.[citado 2024 set. 05 ] Available from: https://doi.org/10.3390/genes12121900
Vancouver
Souza LPC de, Melo CM, Saggioro FP, Reis RB dos, Squire JA. Epithelial–mesenchymal transition signaling and prostate cancer stem cells: emerging biomarkers and opportunities for precision therapeutics [Internet]. Genes. 2021 ; 12( 12): 1-18.[citado 2024 set. 05 ] Available from: https://doi.org/10.3390/genes12121900
Trabalho de evento-resumo periodico
ZEB1 expression is associated with the PTEN loss and TMPRSS2 ERG fusion immune evasion phenotype in prostate cancer (2021)
Souza, Luiz Paulo Chaves; Costa, André Luiz Caliari ; Melo, Camila Morais ; Saggioro, Fabiano Pinto ; Squire, Jeremy Andrew
Fonte: Cancer Research. Nome do evento: Proceedings of the American Association for Cancer Research Annual Meeting. Unidades: SVOI, FMRP
Assuntos: PRÓSTATA, NEOPLASIAS, MUTAÇÃO GENÉTICA, IMUNOHISTOQUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Luiz Paulo Chaves et al. ZEB1 expression is associated with the PTEN loss and TMPRSS2 ERG fusion immune evasion phenotype in prostate cancer. Cancer Research. Philadelphia: , Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.AM2021-1818. Acesso em: 05 set. 2024. , 2021
APA
Souza, L. P. C., Costa, A. L. C., Melo, C. M., Saggioro, F. P., & Squire, J. A. (2021). ZEB1 expression is associated with the PTEN loss and TMPRSS2 ERG fusion immune evasion phenotype in prostate cancer. Cancer Research. Philadelphia: , Universidade de São Paulo. doi:10.1158/1538-7445.AM2021-1818
NLM
Souza LPC, Costa ALC, Melo CM, Saggioro FP, Squire JA. ZEB1 expression is associated with the PTEN loss and TMPRSS2 ERG fusion immune evasion phenotype in prostate cancer [Internet]. Cancer Research. 2021 ; 81[citado 2024 set. 05 ] Available from: https://doi.org/10.1158/1538-7445.AM2021-1818
Vancouver
Souza LPC, Costa ALC, Melo CM, Saggioro FP, Squire JA. ZEB1 expression is associated with the PTEN loss and TMPRSS2 ERG fusion immune evasion phenotype in prostate cancer [Internet]. Cancer Research. 2021 ; 81[citado 2024 set. 05 ] Available from: https://doi.org/10.1158/1538-7445.AM2021-1818
Artigo de periodico
Evaluating H3F3A K27M and G34R/V somatic mutations in a cohort of pediatric brain tumors of different and rare histologies (2020)
Oliveira, Vinicius Fernandes; Sousa, Graziella Ribeiro de ; Santos, Antonio Carlos dos ; Saggioro, Fabiano Pinto ; Machado, Hélio Rubens ; Oliveira, Ricardo Santos de ; Tone, Luiz Gonzaga ; Valera, Elvis Terci
Fonte: Child's Nervous System. Unidades: FMRP, SVOI
Assuntos: NEOPLASIAS CEREBRAIS, EPIGÊNESE GENÉTICA, GLIOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Vinicius Fernandes et al. Evaluating H3F3A K27M and G34R/V somatic mutations in a cohort of pediatric brain tumors of different and rare histologies. Child's Nervous System, v. 37, n. 2, p. 375-382, 2020Tradução . . Disponível em: https://doi.org/10.1007/s00381-020-04852-8. Acesso em: 05 set. 2024.
APA
Oliveira, V. F., Sousa, G. R. de, Santos, A. C. dos, Saggioro, F. P., Machado, H. R., Oliveira, R. S. de, et al. (2020). Evaluating H3F3A K27M and G34R/V somatic mutations in a cohort of pediatric brain tumors of different and rare histologies. Child's Nervous System, 37( 2), 375-382. doi:10.1007/s00381-020-04852-8
NLM
Oliveira VF, Sousa GR de, Santos AC dos, Saggioro FP, Machado HR, Oliveira RS de, Tone LG, Valera ET. Evaluating H3F3A K27M and G34R/V somatic mutations in a cohort of pediatric brain tumors of different and rare histologies [Internet]. Child's Nervous System. 2020 ; 37( 2): 375-382.[citado 2024 set. 05 ] Available from: https://doi.org/10.1007/s00381-020-04852-8
Vancouver
Oliveira VF, Sousa GR de, Santos AC dos, Saggioro FP, Machado HR, Oliveira RS de, Tone LG, Valera ET. Evaluating H3F3A K27M and G34R/V somatic mutations in a cohort of pediatric brain tumors of different and rare histologies [Internet]. Child's Nervous System. 2020 ; 37( 2): 375-382.[citado 2024 set. 05 ] Available from: https://doi.org/10.1007/s00381-020-04852-8
Artigo de periodico
mTOR pathway somatic variants and the molecular pathogenesis of hemimegalencephaly (2020)
Garcia, Camila Araújo Bernardino ; Carvalho, Simone da Costa e Silva; Yang, Xiaoxu; Ball, Laurel L.; George, Renee D.; James, Kiely N.; Stanley, Valentina; Breuss, Martin W; Thome, Úrsula; Santos, Marcelo Volpon ; Saggioro, Fabiano Pinto ; Serafini, Luciano Neder ; Silva Junior, Wilson Araújo da ; Gleeson, Joseph G.; Machado, Hélio Rubens
Fonte: Epilepsia Open. Unidades: FMRP, SVOI
Assuntos: MALFORMAÇÕES, CÉREBRO, FENÓTIPOS, GENÓTIPOS, SEQUENCIAMENTO GENÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GARCIA, Camila Araújo Bernardino et al. mTOR pathway somatic variants and the molecular pathogenesis of hemimegalencephaly. Epilepsia Open, v. 5, n. 1, p. 97-106, 2020Tradução . . Disponível em: https://doi.org/10.1002/epi4.12377. Acesso em: 05 set. 2024.
APA
Garcia, C. A. B., Carvalho, S. da C. e S., Yang, X., Ball, L. L., George, R. D., James, K. N., et al. (2020). mTOR pathway somatic variants and the molecular pathogenesis of hemimegalencephaly. Epilepsia Open, 5( 1), 97-106. doi:10.1002/epi4.12377
NLM
Garcia CAB, Carvalho S da C e S, Yang X, Ball LL, George RD, James KN, Stanley V, Breuss MW, Thome Ú, Santos MV, Saggioro FP, Serafini LN, Silva Junior WA da, Gleeson JG, Machado HR. mTOR pathway somatic variants and the molecular pathogenesis of hemimegalencephaly [Internet]. Epilepsia Open. 2020 ; 5( 1): 97-106.[citado 2024 set. 05 ] Available from: https://doi.org/10.1002/epi4.12377
Vancouver
Garcia CAB, Carvalho S da C e S, Yang X, Ball LL, George RD, James KN, Stanley V, Breuss MW, Thome Ú, Santos MV, Saggioro FP, Serafini LN, Silva Junior WA da, Gleeson JG, Machado HR. mTOR pathway somatic variants and the molecular pathogenesis of hemimegalencephaly [Internet]. Epilepsia Open. 2020 ; 5( 1): 97-106.[citado 2024 set. 05 ] Available from: https://doi.org/10.1002/epi4.12377
Artigo de periodico
Modulation of NMDA receptor by miR-219 in the amygdala and hippocampus of patients with mesial temporal lobe epilepsy (2020)
Hamamoto, Osmi; Tirapelli, Daniela Pretti da Cunha; Lizarte Neto, Fermino Sanches; Freitas-Lima, Priscila; Saggioro, Fabiano Pinto; Cirino, Mucio Luiz de Assis; Assirati Júnior, João Alberto; Neder, Luciano; Velasco, Tonicarlo Rodrigues; Sakamoto, Américo Ceiki; Carlotti Júnior, Carlos Gilberto
Fonte: Journal of Clinical Neuroscience. Unidades: FMRP, SVOI
Assuntos: EPILEPSIA DO LOBO TEMPORAL, MICRORNAS, RECEPTORES DE GLUTAMATO, HIPOCAMPO, REGULAÇÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HAMAMOTO, Osmi et al. Modulation of NMDA receptor by miR-219 in the amygdala and hippocampus of patients with mesial temporal lobe epilepsy. Journal of Clinical Neuroscience, v. 74, p. 180-186, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jocn.2020.02.024. Acesso em: 05 set. 2024.
APA
Hamamoto, O., Tirapelli, D. P. da C., Lizarte Neto, F. S., Freitas-Lima, P., Saggioro, F. P., Cirino, M. L. de A., et al. (2020). Modulation of NMDA receptor by miR-219 in the amygdala and hippocampus of patients with mesial temporal lobe epilepsy. Journal of Clinical Neuroscience, 74, 180-186. doi:10.1016/j.jocn.2020.02.024
NLM
Hamamoto O, Tirapelli DP da C, Lizarte Neto FS, Freitas-Lima P, Saggioro FP, Cirino ML de A, Assirati Júnior JA, Neder L, Velasco TR, Sakamoto AC, Carlotti Júnior CG. Modulation of NMDA receptor by miR-219 in the amygdala and hippocampus of patients with mesial temporal lobe epilepsy [Internet]. Journal of Clinical Neuroscience. 2020 ; 74 180-186.[citado 2024 set. 05 ] Available from: https://doi.org/10.1016/j.jocn.2020.02.024
Vancouver
Hamamoto O, Tirapelli DP da C, Lizarte Neto FS, Freitas-Lima P, Saggioro FP, Cirino ML de A, Assirati Júnior JA, Neder L, Velasco TR, Sakamoto AC, Carlotti Júnior CG. Modulation of NMDA receptor by miR-219 in the amygdala and hippocampus of patients with mesial temporal lobe epilepsy [Internet]. Journal of Clinical Neuroscience. 2020 ; 74 180-186.[citado 2024 set. 05 ] Available from: https://doi.org/10.1016/j.jocn.2020.02.024
Artigo de periodico
USP8 mutations and cell cycle regulation in corticotroph adenomas (2020)
Martins, Clarissa Silva ; Camargo, Renata Costa; Coeli-Lacchini, Fernanda Borchers; Saggioro, Fabiano Pinto ; Moreira, Ayrton Custódio; Castro, Margaret de
Fonte: Hormone and Metabolic Research. Unidades: FMRP, SVOI
Assuntos: ADENOMA, HORMÔNIO ADRENOCORTICOTRÓFICO, CICLO CELULAR, PROTEÍNAS, EXONS, MUTAÇÃO, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTINS, Clarissa Silva et al. USP8 mutations and cell cycle regulation in corticotroph adenomas. Hormone and Metabolic Research, v. 52, n. 2, p. 117-123, 2020Tradução . . Disponível em: https://doi.org/10.1055/a-1089-7806. Acesso em: 05 set. 2024.
APA
Martins, C. S., Camargo, R. C., Coeli-Lacchini, F. B., Saggioro, F. P., Moreira, A. C., & Castro, M. de. (2020). USP8 mutations and cell cycle regulation in corticotroph adenomas. Hormone and Metabolic Research, 52( 2), 117-123. doi:10.1055/a-1089-7806
NLM
Martins CS, Camargo RC, Coeli-Lacchini FB, Saggioro FP, Moreira AC, Castro M de. USP8 mutations and cell cycle regulation in corticotroph adenomas [Internet]. Hormone and Metabolic Research. 2020 ; 52( 2): 117-123.[citado 2024 set. 05 ] Available from: https://doi.org/10.1055/a-1089-7806
Vancouver
Martins CS, Camargo RC, Coeli-Lacchini FB, Saggioro FP, Moreira AC, Castro M de. USP8 mutations and cell cycle regulation in corticotroph adenomas [Internet]. Hormone and Metabolic Research. 2020 ; 52( 2): 117-123.[citado 2024 set. 05 ] Available from: https://doi.org/10.1055/a-1089-7806
Artigo de periodico
PTEN loss in Gleason grade 7 prostate tumors exhibits intratumoral heterogeneity and is associated with unfavorable pathological features (2019)
Albuquerque, Clarissa Gondim Picanço de; Vidotto, Thiago ; Pereira, C. S.; Saggioro, Fabiano Pinto ; Jamaspishvili, T.; Koti, M.; Berman, D. M.; Squire, Jeremy Andrew ; Reis, Rodolfo Borges dos
Fonte: Applied Cancer Research. Unidades: SVOI, FMRP
Assuntos: NEOPLASIAS DOS GENITAIS MASCULINOS, ESCORE DO TESTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALBUQUERQUE, Clarissa Gondim Picanço de et al. PTEN loss in Gleason grade 7 prostate tumors exhibits intratumoral heterogeneity and is associated with unfavorable pathological features. Applied Cancer Research, v. 39, 2019Tradução . . Disponível em: https://doi.org/10.1186/s41241-018-0071-y. Acesso em: 05 set. 2024.
APA
Albuquerque, C. G. P. de, Vidotto, T., Pereira, C. S., Saggioro, F. P., Jamaspishvili, T., Koti, M., et al. (2019). PTEN loss in Gleason grade 7 prostate tumors exhibits intratumoral heterogeneity and is associated with unfavorable pathological features. Applied Cancer Research, 39. doi:10.1186/s41241-018-0071-y
NLM
Albuquerque CGP de, Vidotto T, Pereira CS, Saggioro FP, Jamaspishvili T, Koti M, Berman DM, Squire JA, Reis RB dos. PTEN loss in Gleason grade 7 prostate tumors exhibits intratumoral heterogeneity and is associated with unfavorable pathological features [Internet]. Applied Cancer Research. 2019 ; 39[citado 2024 set. 05 ] Available from: https://doi.org/10.1186/s41241-018-0071-y
Vancouver
Albuquerque CGP de, Vidotto T, Pereira CS, Saggioro FP, Jamaspishvili T, Koti M, Berman DM, Squire JA, Reis RB dos. PTEN loss in Gleason grade 7 prostate tumors exhibits intratumoral heterogeneity and is associated with unfavorable pathological features [Internet]. Applied Cancer Research. 2019 ; 39[citado 2024 set. 05 ] Available from: https://doi.org/10.1186/s41241-018-0071-y
Artigo de periodico
PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells (2019)
Vidotto, Thiago ; Saggioro, Fabiano Pinto ; Jamaspishvili, Tamara; Chesca, Deise Lúcia; Albuquerque, Clarissa Gondim Picanço de; Reis, Rodolfo Borges dos ; Graham, Charles H.; Berman, David M.; Siemens, D. Robert; Squire, Jeremy Andrew ; Koti, Madhuri
Fonte: The Prostate. Unidades: SVOI, FMRP
Assuntos: PRÓSTATA, NEOPLASIAS, SISTEMA IMUNE, REGULAÇÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIDOTTO, Thiago et al. PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells. The Prostate, v. 79, n. 9, p. 969-979, 2019Tradução . . Disponível em: https://doi.org/10.1002/pros.23808. Acesso em: 05 set. 2024.
APA
Vidotto, T., Saggioro, F. P., Jamaspishvili, T., Chesca, D. L., Albuquerque, C. G. P. de, Reis, R. B. dos, et al. (2019). PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells. The Prostate, 79( 9), 969-979. doi:10.1002/pros.23808
NLM
Vidotto T, Saggioro FP, Jamaspishvili T, Chesca DL, Albuquerque CGP de, Reis RB dos, Graham CH, Berman DM, Siemens DR, Squire JA, Koti M. PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells [Internet]. The Prostate. 2019 ; 79( 9): 969-979.[citado 2024 set. 05 ] Available from: https://doi.org/10.1002/pros.23808
Vancouver
Vidotto T, Saggioro FP, Jamaspishvili T, Chesca DL, Albuquerque CGP de, Reis RB dos, Graham CH, Berman DM, Siemens DR, Squire JA, Koti M. PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells [Internet]. The Prostate. 2019 ; 79( 9): 969-979.[citado 2024 set. 05 ] Available from: https://doi.org/10.1002/pros.23808
Artigo de periodico
Lack of KBTBD4 mutations in molecularly classified brazilian medulloblastomas (2019)
Leal, Letícia Ferro ; Cavagna, Rodrigo de Oliveira; Campanella, Nathalia Cristina; Mançano, Bruna; Almeida, Gisele Caravina; Matsushita, Marcus; Almeida Junior, Carlos Roberto; Saggioro, Fabiano Pinto ; Stavale, João Norberto; Malheiros, Suzana M. F.; Lima, Matheus; Hajj, Glaucia N. M.; Neder, Luciano ; Reis, Rui Manuel
Fonte: Journal of Neuropathology and Experimental Neurology. Unidades: SVOI, FMRP
Assuntos: NEOPLASIAS CEREBRAIS, MEDULOBLASTOMA, MUTAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEAL, Letícia Ferro et al. Lack of KBTBD4 mutations in molecularly classified brazilian medulloblastomas. Journal of Neuropathology and Experimental Neurology, v. 78, n. 9, p. 788-790, 2019Tradução . . Disponível em: https://doi.org/10.1093/jnen/nlz066. Acesso em: 05 set. 2024.
APA
Leal, L. F., Cavagna, R. de O., Campanella, N. C., Mançano, B., Almeida, G. C., Matsushita, M., et al. (2019). Lack of KBTBD4 mutations in molecularly classified brazilian medulloblastomas. Journal of Neuropathology and Experimental Neurology, 78( 9), 788-790. doi:10.1093/jnen/nlz066
NLM
Leal LF, Cavagna R de O, Campanella NC, Mançano B, Almeida GC, Matsushita M, Almeida Junior CR, Saggioro FP, Stavale JN, Malheiros SMF, Lima M, Hajj GNM, Neder L, Reis RM. Lack of KBTBD4 mutations in molecularly classified brazilian medulloblastomas [Internet]. Journal of Neuropathology and Experimental Neurology. 2019 ; 78( 9): 788-790.[citado 2024 set. 05 ] Available from: https://doi.org/10.1093/jnen/nlz066
Vancouver
Leal LF, Cavagna R de O, Campanella NC, Mançano B, Almeida GC, Matsushita M, Almeida Junior CR, Saggioro FP, Stavale JN, Malheiros SMF, Lima M, Hajj GNM, Neder L, Reis RM. Lack of KBTBD4 mutations in molecularly classified brazilian medulloblastomas [Internet]. Journal of Neuropathology and Experimental Neurology. 2019 ; 78( 9): 788-790.[citado 2024 set. 05 ] Available from: https://doi.org/10.1093/jnen/nlz066
Artigo de periodico
MicroRNA profile of pediatric pilocytic astrocytomas identifies two tumor-specific signatures when compared to non-neoplastic white matter (2019)
Darrigo Júnior, Luiz Guilherme ; Lira, Régia Caroline Peixoto ; Fedatto, Paola Fernanda ; Marco Antonio, David Santos ; Valera, Elvis Terci ; Aguiar, Simone; Yunes, Jose Andres ; Brandalise, Silvia Regina; Neder, Luciano ; Saggioro, Fabiano Pinto ; Becker, Aline Paixão ; Oliveira, Ricardo Santos de; Machado, Hélio Rubens; Panepucci, Rodrigo Alexandre ; Tone, Luiz Gonzaga ; Scrideli, Carlos Alberto
Fonte: Journal of Neuro-Oncology. Unidades: FMRP, SVOI
Assuntos: NEUROFIBROMATOSES, ASTROCITOMA, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DARRIGO JÚNIOR, Luiz Guilherme et al. MicroRNA profile of pediatric pilocytic astrocytomas identifies two tumor-specific signatures when compared to non-neoplastic white matter. Journal of Neuro-Oncology, v. 141, n. 2, p. 373-382, 2019Tradução . . Disponível em: https://doi.org/10.1007/s11060-018-03042-6. Acesso em: 05 set. 2024.
APA
Darrigo Júnior, L. G., Lira, R. C. P., Fedatto, P. F., Marco Antonio, D. S., Valera, E. T., Aguiar, S., et al. (2019). MicroRNA profile of pediatric pilocytic astrocytomas identifies two tumor-specific signatures when compared to non-neoplastic white matter. Journal of Neuro-Oncology, 141( 2), 373-382. doi:10.1007/s11060-018-03042-6
NLM
Darrigo Júnior LG, Lira RCP, Fedatto PF, Marco Antonio DS, Valera ET, Aguiar S, Yunes JA, Brandalise SR, Neder L, Saggioro FP, Becker AP, Oliveira RS de, Machado HR, Panepucci RA, Tone LG, Scrideli CA. MicroRNA profile of pediatric pilocytic astrocytomas identifies two tumor-specific signatures when compared to non-neoplastic white matter [Internet]. Journal of Neuro-Oncology. 2019 ; 141( 2): 373-382.[citado 2024 set. 05 ] Available from: https://doi.org/10.1007/s11060-018-03042-6
Vancouver
Darrigo Júnior LG, Lira RCP, Fedatto PF, Marco Antonio DS, Valera ET, Aguiar S, Yunes JA, Brandalise SR, Neder L, Saggioro FP, Becker AP, Oliveira RS de, Machado HR, Panepucci RA, Tone LG, Scrideli CA. MicroRNA profile of pediatric pilocytic astrocytomas identifies two tumor-specific signatures when compared to non-neoplastic white matter [Internet]. Journal of Neuro-Oncology. 2019 ; 141( 2): 373-382.[citado 2024 set. 05 ] Available from: https://doi.org/10.1007/s11060-018-03042-6
Artigo de periodico
Reproducibility of the NanoString 22-gene molecular subgroup assay for improved prognostic prediction of medulloblastoma (2018)
Leal, Letícia Ferro; Evangelista, Adriane Feijó; Paula, Flávia Escremim de; Almeida, Gisele Caravina de; Carloni, Adriana C.; Saggioro, Fabiano Pinto; Stavale, João Norberto; Malheiros, Suzana Maria Fleury; Mançano, Bruna; Oliveira, Marco A. de; Luu, Betty; Neder, Luciano; Taylor, Michael D.; Reis, Rui Manuel
Fonte: Neuropathology. Unidades: SVOI, FMRP
Assuntos: MEDULOBLASTOMA, CRIANÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEAL, Letícia Ferro et al. Reproducibility of the NanoString 22-gene molecular subgroup assay for improved prognostic prediction of medulloblastoma. Neuropathology, v. 38, n. 5, p. 475-483, 2018Tradução . . Disponível em: https://doi.org/10.1111/neup.12508. Acesso em: 05 set. 2024.
APA
Leal, L. F., Evangelista, A. F., Paula, F. E. de, Almeida, G. C. de, Carloni, A. C., Saggioro, F. P., et al. (2018). Reproducibility of the NanoString 22-gene molecular subgroup assay for improved prognostic prediction of medulloblastoma. Neuropathology, 38( 5), 475-483. doi:10.1111/neup.12508
NLM
Leal LF, Evangelista AF, Paula FE de, Almeida GC de, Carloni AC, Saggioro FP, Stavale JN, Malheiros SMF, Mançano B, Oliveira MA de, Luu B, Neder L, Taylor MD, Reis RM. Reproducibility of the NanoString 22-gene molecular subgroup assay for improved prognostic prediction of medulloblastoma [Internet]. Neuropathology. 2018 ; 38( 5): 475-483.[citado 2024 set. 05 ] Available from: https://doi.org/10.1111/neup.12508
Vancouver
Leal LF, Evangelista AF, Paula FE de, Almeida GC de, Carloni AC, Saggioro FP, Stavale JN, Malheiros SMF, Mançano B, Oliveira MA de, Luu B, Neder L, Taylor MD, Reis RM. Reproducibility of the NanoString 22-gene molecular subgroup assay for improved prognostic prediction of medulloblastoma [Internet]. Neuropathology. 2018 ; 38( 5): 475-483.[citado 2024 set. 05 ] Available from: https://doi.org/10.1111/neup.12508
Artigo de periodico
Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups (2018)
Salomão, Karina Bezerra; Cruzeiro, Gustavo Alencastro Veiga; Silva, Ricardo Bonfim; Geron, Lenisa; Ramalho, Fernando Silva; Saggioro, Fabiano Pinto; Neder, Luciano; Moreno, Daniel Antunes; Queiroz, Rosane Gomes de Paula; Aguiar, Simone dos Santos; Cardinalli, Izilda; Yunes, José Andres; Brandalise, Silvia Regina; Brassesco, Maria Sol; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Fonte: Journal of Neuro-Oncology. Unidades: FMRP, SVOI, FFCLRP
Assuntos: MEDULOBLASTOMA, GENES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SALOMÃO, Karina Bezerra et al. Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups. Journal of Neuro-Oncology, v. 139, n. 1, p. 33-42, 2018Tradução . . Disponível em: https://doi.org/10.1007/s11060-018-2845-1. Acesso em: 05 set. 2024.
APA
Salomão, K. B., Cruzeiro, G. A. V., Silva, R. B., Geron, L., Ramalho, F. S., Saggioro, F. P., et al. (2018). Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups. Journal of Neuro-Oncology, 139( 1), 33-42. doi:10.1007/s11060-018-2845-1
NLM
Salomão KB, Cruzeiro GAV, Silva RB, Geron L, Ramalho FS, Saggioro FP, Neder L, Moreno DA, Queiroz RG de P, Aguiar S dos S, Cardinalli I, Yunes JA, Brandalise SR, Brassesco MS, Scrideli CA, Tone LG. Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups [Internet]. Journal of Neuro-Oncology. 2018 ; 139( 1): 33-42.[citado 2024 set. 05 ] Available from: https://doi.org/10.1007/s11060-018-2845-1
Vancouver
Salomão KB, Cruzeiro GAV, Silva RB, Geron L, Ramalho FS, Saggioro FP, Neder L, Moreno DA, Queiroz RG de P, Aguiar S dos S, Cardinalli I, Yunes JA, Brandalise SR, Brassesco MS, Scrideli CA, Tone LG. Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups [Internet]. Journal of Neuro-Oncology. 2018 ; 139( 1): 33-42.[citado 2024 set. 05 ] Available from: https://doi.org/10.1007/s11060-018-2845-1
Artigo de periodico
Increased STAT1 expression in high grade serous ovarian cancer is associated with a better outcome (2018)
Josahkian, Juliana A.; Saggioro, Fabiano Pinto; Vidotto, Thiago; Ventura, Henrique Torres; Reis, Francisco José Cândido dos; Sousa, Christiâni Bisinoto de; Tiezzi, Daniel Guimarães; Andrade, Jurandyr Moreira de; Koti, Madhuri; Squire, Jeremy Andrew
Fonte: International Journal of Gynecological Cancer. Unidades: SVOI, FMRP
Assuntos: BIOMARCADORES, ESTUDOS DE COORTES, IMUNOHISTOQUÍMICA, NEOPLASIAS OVARIANAS, FATORES DE RISCO, FATORES DE TRANSCRIÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JOSAHKIAN, Juliana A. et al. Increased STAT1 expression in high grade serous ovarian cancer is associated with a better outcome. International Journal of Gynecological Cancer, v. 28, n. 3, p. 459-465, 2018Tradução . . Disponível em: https://doi.org/10.1097/igc.0000000000001193. Acesso em: 05 set. 2024.
APA
Josahkian, J. A., Saggioro, F. P., Vidotto, T., Ventura, H. T., Reis, F. J. C. dos, Sousa, C. B. de, et al. (2018). Increased STAT1 expression in high grade serous ovarian cancer is associated with a better outcome. International Journal of Gynecological Cancer, 28( 3), 459-465. doi:10.1097/igc.0000000000001193
NLM
Josahkian JA, Saggioro FP, Vidotto T, Ventura HT, Reis FJC dos, Sousa CB de, Tiezzi DG, Andrade JM de, Koti M, Squire JA. Increased STAT1 expression in high grade serous ovarian cancer is associated with a better outcome [Internet]. International Journal of Gynecological Cancer. 2018 ; 28( 3): 459-465.[citado 2024 set. 05 ] Available from: https://doi.org/10.1097/igc.0000000000001193
Vancouver
Josahkian JA, Saggioro FP, Vidotto T, Ventura HT, Reis FJC dos, Sousa CB de, Tiezzi DG, Andrade JM de, Koti M, Squire JA. Increased STAT1 expression in high grade serous ovarian cancer is associated with a better outcome [Internet]. International Journal of Gynecological Cancer. 2018 ; 28( 3): 459-465.[citado 2024 set. 05 ] Available from: https://doi.org/10.1097/igc.0000000000001193
Artigo de periodico
Squamous cell carcinoma originating from adult laryngeal papillomatosis: case report and review of the literature (2018)
El-Achkar, Vivian Narana Ribeiro; Duarte, Andressa; Saggioro, Fabiano Pinto; Mello-Filho, Francisco Veríssimo; León, Jorge Esquiche; Ribeiro-Silva, Alfredo; Kaminagakura, Estela
Fonte: Case Reports in Otolaryngology. Unidades: FMRP, SVOI, FORP
Assuntos: OTORRINOLARINGOLOGIA, CARCINOMA DE CÉLULAS ESCAMOSAS, LARINGE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
EL-ACHKAR, Vivian Narana Ribeiro et al. Squamous cell carcinoma originating from adult laryngeal papillomatosis: case report and review of the literature. Case Reports in Otolaryngology, v. 2018, 2018Tradução . . Disponível em: https://doi.org/10.1155/2018/4362162. Acesso em: 05 set. 2024.
APA
El-Achkar, V. N. R., Duarte, A., Saggioro, F. P., Mello-Filho, F. V., León, J. E., Ribeiro-Silva, A., & Kaminagakura, E. (2018). Squamous cell carcinoma originating from adult laryngeal papillomatosis: case report and review of the literature. Case Reports in Otolaryngology, 2018. doi:10.1155/2018/4362162
NLM
El-Achkar VNR, Duarte A, Saggioro FP, Mello-Filho FV, León JE, Ribeiro-Silva A, Kaminagakura E. Squamous cell carcinoma originating from adult laryngeal papillomatosis: case report and review of the literature [Internet]. Case Reports in Otolaryngology. 2018 ; 2018[citado 2024 set. 05 ] Available from: https://doi.org/10.1155/2018/4362162
Vancouver
El-Achkar VNR, Duarte A, Saggioro FP, Mello-Filho FV, León JE, Ribeiro-Silva A, Kaminagakura E. Squamous cell carcinoma originating from adult laryngeal papillomatosis: case report and review of the literature [Internet]. Case Reports in Otolaryngology. 2018 ; 2018[citado 2024 set. 05 ] Available from: https://doi.org/10.1155/2018/4362162
Artigo de periodico
Impact of the canonical Wnt pathway activation on the pathogenesis and prognosis of adamantinomatous craniopharyngiomas (2018)
Jucá, Carlos Eduardo Barros; Colli, Leandro Machado; Martins, Clarissa Silva; Campanini, Marina Lanciotti; Paixão, Beatriz; Jucá, Renata Viana; Saggioro, Fabiano Pinto; Oliveira, Ricardo Santos de; Moreira, Ayrton Custódio; Machado, Hélio Rubens; Neder, Luciano; Antonini, Sonir Roberto Rauber; Castro, Margaret de
Fonte: Hormone and Metabolic Research. Unidades: FMRP, SVOI
Assuntos: NEOPLASIAS CEREBRAIS, GLÂNDULA PITUITÁRIA, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JUCÁ, Carlos Eduardo Barros et al. Impact of the canonical Wnt pathway activation on the pathogenesis and prognosis of adamantinomatous craniopharyngiomas. Hormone and Metabolic Research, v. 50, n. 7, p. 575-581, 2018Tradução . . Disponível em: https://doi.org/10.1055/a-0593-5956. Acesso em: 05 set. 2024.
APA
Jucá, C. E. B., Colli, L. M., Martins, C. S., Campanini, M. L., Paixão, B., Jucá, R. V., et al. (2018). Impact of the canonical Wnt pathway activation on the pathogenesis and prognosis of adamantinomatous craniopharyngiomas. Hormone and Metabolic Research, 50( 7), 575-581. doi:10.1055/a-0593-5956
NLM
Jucá CEB, Colli LM, Martins CS, Campanini ML, Paixão B, Jucá RV, Saggioro FP, Oliveira RS de, Moreira AC, Machado HR, Neder L, Antonini SRR, Castro M de. Impact of the canonical Wnt pathway activation on the pathogenesis and prognosis of adamantinomatous craniopharyngiomas [Internet]. Hormone and Metabolic Research. 2018 ; 50( 7): 575-581.[citado 2024 set. 05 ] Available from: https://doi.org/10.1055/a-0593-5956
Vancouver
Jucá CEB, Colli LM, Martins CS, Campanini ML, Paixão B, Jucá RV, Saggioro FP, Oliveira RS de, Moreira AC, Machado HR, Neder L, Antonini SRR, Castro M de. Impact of the canonical Wnt pathway activation on the pathogenesis and prognosis of adamantinomatous craniopharyngiomas [Internet]. Hormone and Metabolic Research. 2018 ; 50( 7): 575-581.[citado 2024 set. 05 ] Available from: https://doi.org/10.1055/a-0593-5956
Artigo de periodico
Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection (2018)
Petrilli, Raquel; Eloy, Josimar de Oliveira ; Saggioro, Fabiano Pinto ; Chesca, Deise Lúcia; Souza, Marina Claro de; Dias, Marcos Vinicios Salles; Silva, Luis Lamberti Pinto da ; Lee, Robert J.; Lopez, Renata Fonseca Vianna
Fonte: Journal of Controlled Release. Unidades: SVOI, FMRP, FCFRP
Assuntos: MODELOS ANIMAIS, CARCINOMA DE CÉLULAS ESCAMOSAS, TUMOR CARCINOIDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PETRILLI, Raquel et al. Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection. Journal of Controlled Release, v. 283, p. 151-162, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.jconrel.2018.05.038. Acesso em: 05 set. 2024.
APA
Petrilli, R., Eloy, J. de O., Saggioro, F. P., Chesca, D. L., Souza, M. C. de, Dias, M. V. S., et al. (2018). Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection. Journal of Controlled Release, 283, 151-162. doi:10.1016/j.jconrel.2018.05.038
NLM
Petrilli R, Eloy J de O, Saggioro FP, Chesca DL, Souza MC de, Dias MVS, Silva LLP da, Lee RJ, Lopez RFV. Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection [Internet]. Journal of Controlled Release. 2018 ; 283 151-162.[citado 2024 set. 05 ] Available from: https://doi.org/10.1016/j.jconrel.2018.05.038
Vancouver
Petrilli R, Eloy J de O, Saggioro FP, Chesca DL, Souza MC de, Dias MVS, Silva LLP da, Lee RJ, Lopez RFV. Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection [Internet]. Journal of Controlled Release. 2018 ; 283 151-162.[citado 2024 set. 05 ] Available from: https://doi.org/10.1016/j.jconrel.2018.05.038
Artigo de periodico
Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy (2017)
Eloy, Josimar O.; Petrilli, Raquel; Chesca, Deise Lúcia; Saggioro, Fabiano Pinto; Lee, Robert J.; Marchetti, Juliana Maldonado
Fonte: European Journal of Pharmaceutics and Biopharmaceutics. Unidades: FMRP, SVOI, FCFRP
Assuntos: ANTICORPOS MONOCLONAIS, NEOPLASIAS MAMÁRIAS, LIPOSSOMOS, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ELOY, Josimar O. et al. Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy. European Journal of Pharmaceutics and Biopharmaceutics, v. 115, p. 159-167, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2017.02.020. Acesso em: 05 set. 2024.
APA
Eloy, J. O., Petrilli, R., Chesca, D. L., Saggioro, F. P., Lee, R. J., & Marchetti, J. M. (2017). Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy. European Journal of Pharmaceutics and Biopharmaceutics, 115, 159-167. doi:10.1016/j.ejpb.2017.02.020
NLM
Eloy JO, Petrilli R, Chesca DL, Saggioro FP, Lee RJ, Marchetti JM. Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2017 ; 115 159-167.[citado 2024 set. 05 ] Available from: https://doi.org/10.1016/j.ejpb.2017.02.020
Vancouver
Eloy JO, Petrilli R, Chesca DL, Saggioro FP, Lee RJ, Marchetti JM. Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2017 ; 115 159-167.[citado 2024 set. 05 ] Available from: https://doi.org/10.1016/j.ejpb.2017.02.020
Trabalho de evento-resumo
PTEN loss associates with STAT1/3 expression and intra-tumoral CD8+ density in prostate cancer (2016)
Vidotto, Thiago; Ouellet, Véronique; Saggioro, Fabiano Pinto; Caron, Christine; Fragoso, Gabriela; Mes-Masson, Anne-Marie; Saad, Fred; Siemens, D. Robert; Squire, Jeremy Andrew; Koti, Madhuri
Fonte: Abstracts. Nome do evento: Cancer Genomics Group Meetings. Unidades: SVOI, FMRP
Assuntos: NEOPLASIAS PROSTÁTICAS, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIDOTTO, Thiago et al. PTEN loss associates with STAT1/3 expression and intra-tumoral CD8+ density in prostate cancer. 2016, Anais.. Ontario: Queen's University, 2016. . Acesso em: 05 set. 2024.
APA
Vidotto, T., Ouellet, V., Saggioro, F. P., Caron, C., Fragoso, G., Mes-Masson, A. -M., et al. (2016). PTEN loss associates with STAT1/3 expression and intra-tumoral CD8+ density in prostate cancer. In Abstracts. Ontario: Queen's University.
NLM
Vidotto T, Ouellet V, Saggioro FP, Caron C, Fragoso G, Mes-Masson A-M, Saad F, Siemens DR, Squire JA, Koti M. PTEN loss associates with STAT1/3 expression and intra-tumoral CD8+ density in prostate cancer. Abstracts. 2016 ;[citado 2024 set. 05 ]
Vancouver
Vidotto T, Ouellet V, Saggioro FP, Caron C, Fragoso G, Mes-Masson A-M, Saad F, Siemens DR, Squire JA, Koti M. PTEN loss associates with STAT1/3 expression and intra-tumoral CD8+ density in prostate cancer. Abstracts. 2016 ;[citado 2024 set. 05 ]
Artigo de periodico
Lymph node or perineural invasion is associated with low mirR-15a, miR-34c and miR-199b levels in head and neck squamous cell carcinoma (2016)
Sousa, Lucas O.; Sobral, Lays M.; Matsumoto, Camila S.; Saggioro, Fabiano Pinto; López, Rossana Verónica Mendoza; Panepucci, Rodrigo Alexandre; Curti, Carlos; Silva Júnior, Wilson Araújo da; Greene, Lewis Joel; Leopoldino, Andréia Machado
Fonte: BBA- Biochimica et Biophysica Acta. Clinical. Unidades: SVOI, FCFRP, FMRP
Assuntos: LINFONODOS, CARCINOMA DE CÉLULAS ESCAMOSAS, DIAGNÓSTICO, TERAPÊUTICA MÉDICA, RNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUSA, Lucas O. et al. Lymph node or perineural invasion is associated with low mirR-15a, miR-34c and miR-199b levels in head and neck squamous cell carcinoma. BBA- Biochimica et Biophysica Acta. Clinical, v. 6, p. 159-164, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.bbacli.2016.11.001. Acesso em: 05 set. 2024.
APA
Sousa, L. O., Sobral, L. M., Matsumoto, C. S., Saggioro, F. P., López, R. V. M., Panepucci, R. A., et al. (2016). Lymph node or perineural invasion is associated with low mirR-15a, miR-34c and miR-199b levels in head and neck squamous cell carcinoma. BBA- Biochimica et Biophysica Acta. Clinical, 6, 159-164. doi:10.1016/j.bbacli.2016.11.001
NLM
Sousa LO, Sobral LM, Matsumoto CS, Saggioro FP, López RVM, Panepucci RA, Curti C, Silva Júnior WA da, Greene LJ, Leopoldino AM. Lymph node or perineural invasion is associated with low mirR-15a, miR-34c and miR-199b levels in head and neck squamous cell carcinoma [Internet]. BBA- Biochimica et Biophysica Acta. Clinical. 2016 ; 6 159-164.[citado 2024 set. 05 ] Available from: https://doi.org/10.1016/j.bbacli.2016.11.001
Vancouver
Sousa LO, Sobral LM, Matsumoto CS, Saggioro FP, López RVM, Panepucci RA, Curti C, Silva Júnior WA da, Greene LJ, Leopoldino AM. Lymph node or perineural invasion is associated with low mirR-15a, miR-34c and miR-199b levels in head and neck squamous cell carcinoma [Internet]. BBA- Biochimica et Biophysica Acta. Clinical. 2016 ; 6 159-164.[citado 2024 set. 05 ] Available from: https://doi.org/10.1016/j.bbacli.2016.11.001

Unidades USP

ReP

Filtros

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

Editora

Nome do evento

País de publicação

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada